Patients who received a tobacco cessation intervention if identified as a current tobacco user

• OR –

Patients who received a relapse prevention intervention if identified as a recent tobacco user

To qualify for the numerator, the tobacco cessation or relapse prevention intervention must be documented in the patient's outpatient CR record. If a patient had previously received a treatment referral or pharmacotherapy from another clinician (such as the patient's primary physician or cardiologist), these interventions must be documented in the CR record to quality for this performance measure. Tobacco cessation intervention includes any 1 of the following:

1) Tobacco cessation counselling. If the patient is not willing to make a quit attempt, intervention should be aimed at helping the patient improve their readiness for an eventual quit attempt. 2) Tobacco cessation pharmacotherapy. Medication may be provided to patients who are not yet ready to quit, but who are ready to reduce to quit.
3) Referral to a tobacco treatment program or specialist.

Current tobacco use is defined as use of any kind of tobacco product in the 30 days prior to enrolling in CR. This includes cigarettes, cigars, cigarillos, chew tobacco, and e-cigarettes. Relapse prevention intervention includes any 1 of the following: 1) Tobacco relapse prevention counselling.
2) Tobacco cessation pharmacotherapy. 3) Referral to a tobacco treatment program or specialist.

Recent tobacco use is defined as use of any kind of tobacco product in the 6 months prior to enrolling in CR. This includes cigarettes, cigars, cigarillos, chew tobacco, and e-cigarettes.

Number of participants in the CR program during the measurement period who were identified as either a current or recent tobacco user at program entry. This includes all participants in the CR program regardless of length of participation in program (1 or more sessions.)

Denominator Exclusions Documentation of a medical reason for not receiving tobacco cessation intervention or tobacco relapse prevention intervention (e.g., limited life expectancy).

Data Sources: Medical record or another database (e.g., administrative, clinical, registry).

Pack QR, Bauldoff G, Lichtman SW, Buckley M, Eichenauer K, Gavic A, Garvey C, King ML; American Association of Cardiovascular and Pulmonary Rehabilitation Quality of Care Committee. Prioritization, Development, and Validation of American Association of Cardiovascular and Pulmonary Rehabilitation Performance Measures. J Cardiopulm Rehabil Prev. 2018 Jul;38(4):208-214. doi: 10.1097/HCR.0000000000000358

Supplement of journals.lww.com/jcrjournal/Fulltext/2018/07000/Prioritization,Development,andValidationof.2.aspx